n/a
Cimadamore A., Cheng L., Scarpelli M., Lopez-Beltran A., Mollica V., Montironi R., et al. (2021). Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation. EUROPEAN UROLOGY, 79(1), 17-19 [10.1016/j.eururo.2020.09.047].
Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation
Mollica V.;Massari F.
2021
Abstract
n/aFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
